Enerkon Solar International Inc. (ENKS) Files Q2 March 31 Report
Retrieved on:
Thursday, May 6, 2021
b'New York, New York--(Newsfile Corp. - May 6, 2021) - Enerkon Solar International (OTC Pink: ENKS) announces today the filling of Q2 March 31 Report today with the OTC Markets and positive Revenue and Growth and agrees to Appoint Famous Biotech Analyst Dr. Harvey Tran as Board Consultant and Adviser.\nIn other news, ENKS agrees to Appoint Famous Biotech Analyst Dr. Harvey Tran as Board Consultant and Adviser to ENKS.
Key Points:
- b'New York, New York--(Newsfile Corp. - May 6, 2021) - Enerkon Solar International (OTC Pink: ENKS) announces today the filling of Q2 March 31 Report today with the OTC Markets and positive Revenue and Growth and agrees to Appoint Famous Biotech Analyst Dr. Harvey Tran as Board Consultant and Adviser.\nIn other news, ENKS agrees to Appoint Famous Biotech Analyst Dr. Harvey Tran as Board Consultant and Adviser to ENKS.
- Dr. Tran will add value and visibility of the company as well as more breadth to analyst and other coverage expected once he is engaged starting next week.\nENKS is also pleased to announce the Land Contract and Agreement to Purchase of 122 Acres of Commercial Land in Pennsylvania Turnpike area for the establishment of its planned 20 MW Solar and Hydrogen Plant facility has been completed with deed of sale, undergoing final edits for signature this week.\nTo view an enhanced version of this graphic, please visit:\nThe Land area is located in the Penn Forest Township carbon county commonwealth having its exact location and legal personality referenced in book 2467 page 49 specifically, such land being in the State of Pennsylvania straddling the turnpike with service road access - having also a freshwater lake for water source needed in Electrolysis (Hydrogen Production) - and an adjacent Transformer station which connects to the Electricity Grid for the State of Pennsylvania.\nTo view an enhanced version of this graphic, please visit:\n'